Invivoscribe(R) Launches LeukoStrat(R) KMT2A + MRD Assay to Advance High-Sensitivity Leukemia Testing in Clinical Trials and Patient Management Worldwide

Invivoscribe, a leader in precision medicine and measurable residual disease (MRD) testing, today announced the addition of the LeukoStrat(R) KMT2A + MRD Assay and Software to its industry-leading ...
Precision Medicine Online

Mira Precision Health Enters US DPYD Testing Market With Expanded Assay for Chemo Risks

Mira is bringing its version of Oxford Cancer Biomarkers' PGx test to the US in the newly launched ToxNav Advantage assay.
The American Journal of Managed Care

Diagnosis Patterns and Stress Testing Trends After Implementing High-Sensitivity Troponin Assay

This study found that switching from a conventional troponin assay to a high-sensitivity troponin assay resulted in changes to diagnosis patterns and stress testing trends. Objectives: ...
ascopubs.org

Validation of ctDNA Quality Control Materials Through a Precompetitive Collaboration of the Foundation for the National Institutes of Health

Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non–Small-Cell Lung Cancer The two droplet digital polymerase chain reaction assays reported VAF values very close to the ...
News Medical

INNOVANCE Antithrombin Assay

INNOVANCE Antithrombin assay is a cutting-edge, ready-to-use chromogenic reagent for the automated determination of antithrombin (AT) activity. It is highly accurate even at low activity levels and ...
Pharmabiz

Invivoscribe introduces LeukoStrat KMT2A + MRD Assay to advance high-sensitivity leukaemia testing in clinical trials and patient management worldwide

Invivoscribe introduces LeukoStrat KMT2A + MRD Assay to advance high-sensitivity leukaemia testing in clinical trials and patient management worldwide: San Diego Friday, February ...